Life saving early and immediate aspirin: too little too late [Editorial]

Woollard, M., Elwood, Peter Creighton and Morgan, Gareth 2008. Life saving early and immediate aspirin: too little too late [Editorial]. Postgraduate Medical Journal 84 (993) , pp. 337-338. 10.1136/pgmj.2008.068221

Full text not available from this repository.

Abstract

The first randomised controlled trial of aspirin in the prevention of vascular events was conducted in South Wales in 1974.1 Since then overviews of numerous trials2 3 have established aspirin, used in cardiovascular disease, as the most thoroughly tested and the most highly cost effective drug available in clinical practice. Aspirin is now a standard part of both the early and the long term management of coronary thrombosis. Unfortunately, there is evidence that within Wales only about half such patients are actually taking this drug.4 Other research has identified that poor compliance is not confined to Wales. A number of doctors taking part in the US Physicians Health Study admitted that they had taken aspirin on less than half the study days.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	BMJ Publishing Group
ISSN:	0032-5473
Last Modified:	10 Jun 2023 01:14
URI:	https://orca.cardiff.ac.uk/id/eprint/29221

Actions (repository staff only)

Edit Item